It has indeed been shown that immunosuppressive CD33+ cells isolated from breast cancers patients are able to induce a stemness phenotype (associated with cancer cell chemoresistance) in the breast cancer cell line MCF-7 (64). Here, CD33 is linked to breast carcinoma.